DGI:Opportunistische Infektionen/Zerebrale Toxoplasmose/Quellen: Difference between revisions
imported>Bestem m (Bestem verschob die Seite DGI:Zerebrale Toxoplasmose/Quellen nach DGI:Opportunistische Infektionen/Zerebrale Toxoplasmose/Quellen) |
imported>Bestem No edit summary |
||
| Line 1: | Line 1: | ||
#<span style="color: black">https://www.rki.de/DE/Content/Infekt/EpidBull/Merkblaetter/Ratgeber_Toxoplasmose.html;jsessionid=6F4003131E144DDB68FB03F9762455B6.internet082</span> | #<span style="color: black">https://www.rki.de/DE/Content/Infekt/EpidBull/Merkblaetter/Ratgeber_Toxoplasmose.html;jsessionid=6F4003131E144DDB68FB03F9762455B6.internet082</span> | ||
Revision as of 13:03, 23 November 2021
- https://www.rki.de/DE/Content/Infekt/EpidBull/Merkblaetter/Ratgeber_Toxoplasmose.html;jsessionid=6F4003131E144DDB68FB03F9762455B6.internet082
- Pleyer U, Gross U, Schlüter D, Wilking H, Seeber F. Toxoplasmosis in Germany. Dtsch Arztebl Int. 2019;116(25):435-444. doi:10.3238/arztebl.2019.0435
- Schmidt-Hieber M, Silling G, Schalk E, et al. CNS infections in patients with hematological disorders (including allogeneic stem-cell transplantation)-Guidelines of the Infectious Diseases Working Party (AGIHO) of the German Society of Hematology and Medical Oncology (DGHO). Ann Oncol. 2016;27(7):1207-1225. doi:10.1093/annonc/mdw155
- Ullmann AJ, Schmidt-Hieber M, Bertz H, et al. Infectious diseases in allogeneic haematopoietic stem cell transplantation: prevention and prophylaxis strategy guidelines 2016. Ann Hematol. 2016;95(9):1435-1455. doi:10.1007/s00277-016-2711-1
- LL OI 2014-2.pdf. Accessed November 7, 2021. https://daignet.de/site-content/hiv-leitlinien/leitlinien-1/LL%20OI%202014-2.pdf